Related Experiment Video
Updated: Jul 3, 2026

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
Published on: October 16, 2013
Capsule endoscopy may reclassify pediatric inflammatory bowel disease: a historical analysis
Stanley A Cohen1, Ian M Gralnek, Hagit Ephrath
1Children's Center for Digestive Health Care, Children's Healthcare of Atlanta, Atlanta, GA 30342, USA. stancohen@aol.com
Capsule endoscopy reclassified 71% of pediatric ulcerative colitis/indeterminate colitis patients to Crohn disease. It also revealed more extensive small bowel disease in existing Crohn disease patients, enabling targeted therapies.
Area of Science:
- Pediatric Gastroenterology
- Inflammatory Bowel Disease Research
- Diagnostic Endoscopy
Background:
- Limited data exists on capsule endoscopy's role in pediatric inflammatory bowel disease (IBD) diagnosis and management.
- Capsule endoscopy (CE) was evaluated for its ability to identify new disease locations in pediatric IBD patients.
Purpose of the Study:
- To assess if CE can alter IBD diagnosis and improve patient management.
- To evaluate CE's impact on reclassifying disease type and extent in pediatric IBD.
Main Methods:
- Retrospective cohort analysis of 28 symptomatic pediatric IBD patients.
- CE performed 4.2 years post-diagnosis due to disease exacerbation, growth issues, or pre-surgical evaluation.
- Patients initially diagnosed with ulcerative colitis (UC), indeterminate colitis (IC), or Crohn disease (CD).
Main Results:
- 71% of UC/IC patients were reclassified to CD based on new small bowel lesions identified by CE.
- 62% of CD patients showed more extensive small bowel disease, with 92% newly diagnosed with jejunal disease.
- Therapeutic changes were made in all 5 newly diagnosed CD patients; one capsule retention occurred.
Conclusions:
- Capsule endoscopy can reclassify pediatric IBD from UC/IC to CD.
- CE identifies a greater small bowel disease burden in pediatric CD patients.
- This diagnostic information supports more targeted therapies and potentially improved outcomes.
Related Concept Videos
Endoscopic Procedures III: Video Capsule Endoscopy
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...